SEC Form 4 · accession 0001878313-26-000082
MAIA Biotechnology, Inc. · MAIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramiro Guerrero
Director
Period of report
Aug 26, 2026
Accepted (ET)
Sep 1, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001878313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2026 | P | 8,931 | $1.39 | A | 610,842 | D | |
| Common Stock | Aug 27, 2026 | P | 78,239 | $1.39 | A | 689,081 | D | |
| Common Stock | Aug 28, 2026 | P | 46,620 | $1.35 | A | 735,701 | D |
Table II — derivative securities
No Table II lines on this filing.